These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 11372000)
1. Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: an investigation comparing single and multiple dosing. Busse D; Fromm MF; Mörike K; Drescher S; Kühlkamp V; Eichelbaum M Clin Pharmacol Ther; 2001 May; 69(5):324-32. PubMed ID: 11372000 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans: a placebo-controlled study. Busse D; Templin S; Mikus G; Schwab M; Hofmann U; Eichelbaum M; Kivistö KT Eur J Clin Pharmacol; 2006 Aug; 62(8):613-9. PubMed ID: 16823584 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of the enantiomers of verapamil after intravenous and oral administration of racemic verapamil in a rat model. Bhatti MM; Foster RT Biopharm Drug Dispos; 1997 Jul; 18(5):387-96. PubMed ID: 9210977 [TBL] [Abstract][Full Text] [Related]
4. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter. Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606 [TBL] [Abstract][Full Text] [Related]
5. Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers. Ho PC; Ghose K; Saville D; Wanwimolruk S Eur J Clin Pharmacol; 2000 Dec; 56(9-10):693-8. PubMed ID: 11214778 [TBL] [Abstract][Full Text] [Related]
6. Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses. Carosella L; Menichelli P; Alimenti M; Zuccala G; Gemma A; Cocchi A; Carbonin PU Cardiovasc Drugs Ther; 1989 Jun; 3(3):417-25. PubMed ID: 2487538 [TBL] [Abstract][Full Text] [Related]
7. The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates. Lemma GL; Wang Z; Hamman MA; Zaheer NA; Gorski JC; Hall SD Clin Pharmacol Ther; 2006 Mar; 79(3):218-30. PubMed ID: 16513446 [TBL] [Abstract][Full Text] [Related]
10. Effect of atorvastatin on the intravenous and oral pharmacokinetics of verapamil in rats. Choi DH; Chang KS; Hong SP; Choi JS; Han HK Biopharm Drug Dispos; 2008 Jan; 29(1):45-50. PubMed ID: 17941000 [TBL] [Abstract][Full Text] [Related]
11. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin. Fromm MF; Busse D; Kroemer HK; Eichelbaum M Hepatology; 1996 Oct; 24(4):796-801. PubMed ID: 8855178 [TBL] [Abstract][Full Text] [Related]
12. A combined accelerator mass spectrometry-positron emission tomography human microdose study with 14C- and 11C-labelled verapamil. Wagner CC; Simpson M; Zeitlinger M; Bauer M; Karch R; Abrahim A; Feurstein T; Schütz M; Kletter K; Müller M; Lappin G; Langer O Clin Pharmacokinet; 2011 Feb; 50(2):111-20. PubMed ID: 21142292 [TBL] [Abstract][Full Text] [Related]
13. Modulation of ventricular rate in permanent atrial fibrillation: randomized, crossover study of the effects of slow-release formulations of gallopamil, diltiazem, or verapamil. Botto GL; Bonini W; Broffoni T Clin Cardiol; 1998 Nov; 21(11):837-40. PubMed ID: 9825197 [TBL] [Abstract][Full Text] [Related]
14. Non-linear pharmacokinetics of high-dose intravenous verapamil. Toffoli G; Robieux I; Fantin D; Gigante M; Frustaci S; Nicolosi GL; De Cicco M; Boiocchi M Br J Clin Pharmacol; 1997 Sep; 44(3):255-60. PubMed ID: 9296319 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of verapamil and norverapamil enantiomers after administration of immediate and controlled-release formulations to humans:evidence suggesting input-rate determined stereoselectivity. Bhatti MM; Lewanczuk RZ; Pasutto FM; Foster RT J Clin Pharmacol; 1995 Nov; 35(11):1076-82. PubMed ID: 8626881 [TBL] [Abstract][Full Text] [Related]
16. Effect of oral L-type calcium channel blocker on repetitive paroxysmal atrial fibrillation: spectral analysis of fibrillation waves in the Holter monitoring. Niwano S; Fukaya H; Sasaki T; Hatakeyama Y; Fujiki A; Izumi T Europace; 2007 Dec; 9(12):1209-15. PubMed ID: 17897926 [TBL] [Abstract][Full Text] [Related]
17. Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation. Shenasa M; Kus T; Fromer M; LeBlanc RA; Dubuc M; Nadeau R Am J Cardiol; 1988 Sep; 62(7):403-7. PubMed ID: 3414517 [TBL] [Abstract][Full Text] [Related]
18. [Amiodarone and verapamil/quinidine in treatment of patients with chronic atrial fibrillation]. Zehender M; Meinertz T; Just H Z Kardiol; 1994; 83 Suppl 5():101-8. PubMed ID: 7846938 [TBL] [Abstract][Full Text] [Related]
19. Reduction of enantioselectivity in the kinetic disposition and metabolism of verapamil in rats exposed to toluene. Mateus FH; Lepera JS; Marques MP; Boralli VB; Lanchote VL Can J Physiol Pharmacol; 2008 May; 86(5):232-9. PubMed ID: 18432283 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of the enantiomers of verapamil in the dog. Bai SA; Lankford SM; Johnson LM Chirality; 1993; 5(6):436-42. PubMed ID: 8398603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]